Anika Therapeutics, Inc. (ANIK)
USD 14.69
(-2.39%)
USD 14.69
(-2.39%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -87.63 Million USD | -31.18% |
| 2022 | -19.4 Million USD | -4.98% |
| 2021 | -18.48 Million USD | -27.73% |
| 2020 | -14.46 Million USD | -142.24% |
| 2019 | 34.24 Million USD | 57.47% |
| 2018 | 21.74 Million USD | -52.44% |
| 2017 | 45.72 Million USD | -9.64% |
| 2016 | 50.6 Million USD | 5.14% |
| 2015 | 48.13 Million USD | -21.67% |
| 2014 | 61.44 Million USD | 88.45% |
| 2013 | 32.6 Million USD | 65.39% |
| 2012 | 19.71 Million USD | 41.15% |
| 2011 | 13.96 Million USD | 85.3% |
| 2010 | 7.53 Million USD | 34.92% |
| 2009 | 5.58 Million USD | 32.18% |
| 2008 | 4.22 Million USD | -35.84% |
| 2007 | 6.58 Million USD | 21.37% |
| 2006 | 5.42 Million USD | -36.53% |
| 2005 | 8.55 Million USD | 33.86% |
| 2004 | 6.38 Million USD | 973.61% |
| 2003 | 595 Thousand USD | 118.17% |
| 2002 | -3.27 Million USD | 55.81% |
| 2001 | -7.41 Million USD | -653.61% |
| 2000 | -983.36 Thousand USD | -883.37% |
| 1999 | -100 Thousand USD | -103.13% |
| 1998 | 3.2 Million USD | 0.0% |
| 1997 | 3.2 Million USD | 218.52% |
| 1996 | -2.7 Million USD | -42.11% |
| 1995 | -1.9 Million USD | -35.71% |
| 1994 | -1.4 Million USD | 26.32% |
| 1993 | -1.9 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -5.06 Million USD | -218.23% |
| 2024 Q2 | 161 Thousand USD | 103.18% |
| 2024 Q3 | -24.91 Million USD | -17501.86% |
| 2023 FY | -25.44 Million USD | -31.18% |
| 2023 Q1 | -12.55 Million USD | -88.29% |
| 2023 Q2 | -3.63 Million USD | 71.07% |
| 2023 Q4 | -1.59 Million USD | 79.27% |
| 2023 Q3 | -7.67 Million USD | -111.35% |
| 2022 Q1 | -3.55 Million USD | 61.04% |
| 2022 Q2 | -3.38 Million USD | 4.87% |
| 2022 FY | -19.4 Million USD | -4.98% |
| 2022 Q3 | -5.79 Million USD | -71.49% |
| 2022 Q4 | -6.66 Million USD | -14.99% |
| 2021 Q2 | 9.18 Million USD | 629.73% |
| 2021 FY | -18.48 Million USD | -27.73% |
| 2021 Q4 | -9.12 Million USD | -801.77% |
| 2021 Q1 | 1.25 Million USD | 107.01% |
| 2021 Q3 | 1.3 Million USD | -85.84% |
| 2020 FY | -14.46 Million USD | -142.24% |
| 2020 Q1 | 4.99 Million USD | 3.96% |
| 2020 Q2 | -9.53 Million USD | -291.03% |
| 2020 Q4 | -17.95 Million USD | -126.47% |
| 2020 Q3 | -7.92 Million USD | 16.87% |
| 2019 FY | 34.24 Million USD | 57.47% |
| 2019 Q1 | 5.48 Million USD | -43.84% |
| 2019 Q2 | 11.91 Million USD | 117.35% |
| 2019 Q3 | 12.04 Million USD | 1.12% |
| 2019 Q4 | 4.8 Million USD | -60.15% |
| 2018 FY | 21.74 Million USD | -52.44% |
| 2018 Q4 | 9.76 Million USD | 13.87% |
| 2018 Q1 | -7.83 Million USD | -180.51% |
| 2018 Q3 | 8.57 Million USD | -23.77% |
| 2018 Q2 | 11.24 Million USD | 243.59% |
| 2017 Q4 | 9.72 Million USD | -5.27% |
| 2017 Q2 | 17.72 Million USD | 121.41% |
| 2017 Q1 | 8 Million USD | -37.16% |
| 2017 Q3 | 10.26 Million USD | -42.07% |
| 2017 FY | 45.72 Million USD | -9.64% |
| 2016 FY | 50.6 Million USD | 5.14% |
| 2016 Q4 | 12.74 Million USD | -6.93% |
| 2016 Q3 | 13.68 Million USD | 1.63% |
| 2016 Q2 | 13.46 Million USD | 25.77% |
| 2016 Q1 | 10.7 Million USD | -37.24% |
| 2015 Q4 | 17.06 Million USD | 29.91% |
| 2015 Q2 | 12.42 Million USD | 125.79% |
| 2015 Q1 | 5.5 Million USD | -54.46% |
| 2015 FY | 48.13 Million USD | -21.67% |
| 2015 Q3 | 13.13 Million USD | 5.68% |
| 2014 Q4 | 12.08 Million USD | 17.51% |
| 2014 Q3 | 10.28 Million USD | -32.34% |
| 2014 FY | 61.44 Million USD | 88.45% |
| 2014 Q1 | 23.87 Million USD | 128.85% |
| 2014 Q2 | 15.2 Million USD | -36.31% |
| 2013 FY | 32.6 Million USD | 65.39% |
| 2013 Q4 | 10.43 Million USD | 34.31% |
| 2013 Q3 | 7.76 Million USD | -17.37% |
| 2013 Q2 | 9.39 Million USD | 87.54% |
| 2013 Q1 | 5.01 Million USD | -35.68% |
| 2012 Q1 | 3.06 Million USD | -37.69% |
| 2012 Q4 | 7.79 Million USD | 185.74% |
| 2012 FY | 19.71 Million USD | 41.15% |
| 2012 Q3 | 2.72 Million USD | -55.55% |
| 2012 Q2 | 6.13 Million USD | 100.25% |
| 2011 Q1 | 556.67 Thousand USD | -77.54% |
| 2011 Q4 | 4.91 Million USD | 2.04% |
| 2011 FY | 13.96 Million USD | 85.3% |
| 2011 Q2 | 3.67 Million USD | 560.63% |
| 2011 Q3 | 4.81 Million USD | 30.99% |
| 2010 FY | 7.53 Million USD | 34.92% |
| 2010 Q3 | 2.07 Million USD | 15.17% |
| 2010 Q2 | 1.8 Million USD | 53.17% |
| 2010 Q4 | 2.47 Million USD | 19.28% |
| 2010 Q1 | 1.17 Million USD | -26.54% |
| 2009 Q2 | 1.2 Million USD | 59.04% |
| 2009 Q1 | 759.36 Thousand USD | -39.18% |
| 2009 FY | 5.58 Million USD | 32.18% |
| 2009 Q3 | 2.01 Million USD | 66.94% |
| 2009 Q4 | 1.6 Million USD | -20.48% |
| 2008 Q1 | 755.75 Thousand USD | -64.37% |
| 2008 Q4 | 1.24 Million USD | -6.22% |
| 2008 Q3 | 1.33 Million USD | 49.45% |
| 2008 FY | 4.22 Million USD | -35.84% |
| 2008 Q2 | 890.88 Thousand USD | 17.88% |
| 2007 Q2 | 1.36 Million USD | 11.52% |
| 2007 FY | 6.58 Million USD | 21.37% |
| 2007 Q4 | 2.12 Million USD | 12.79% |
| 2007 Q3 | 1.88 Million USD | 37.89% |
| 2007 Q1 | 1.22 Million USD | 40.46% |
| 2006 Q2 | 1.8 Million USD | 73.25% |
| 2006 Q4 | 870.51 Thousand USD | -49.3% |
| 2006 Q3 | 1.71 Million USD | -4.65% |
| 2006 Q1 | 1.03 Million USD | 21.14% |
| 2006 FY | 5.42 Million USD | -36.53% |
| 2005 FY | 8.55 Million USD | 33.86% |
| 2005 Q4 | 858 Thousand USD | -78.11% |
| 2005 Q3 | 3.91 Million USD | 99.24% |
| 2005 Q2 | 1.96 Million USD | 8.91% |
| 2005 Q1 | 1.8 Million USD | -24.24% |
| 2004 Q2 | 1.28 Million USD | 6.89% |
| 2004 FY | 6.38 Million USD | 973.61% |
| 2004 Q4 | 2.38 Million USD | 57.78% |
| 2004 Q3 | 1.51 Million USD | 17.31% |
| 2004 Q1 | 1.2 Million USD | 44.48% |
| 2003 Q1 | -509 Thousand USD | -183.3% |
| 2003 FY | 595 Thousand USD | 118.17% |
| 2003 Q4 | 834 Thousand USD | 113.3% |
| 2003 Q3 | 391 Thousand USD | 423.14% |
| 2003 Q2 | -121 Thousand USD | 76.23% |
| 2002 Q3 | -798.73 Thousand USD | 34.51% |
| 2002 FY | -3.27 Million USD | 55.81% |
| 2002 Q1 | -1.86 Million USD | -247.84% |
| 2002 Q2 | -1.21 Million USD | 34.67% |
| 2002 Q4 | 611.02 Thousand USD | 176.5% |
| 2001 FY | -7.41 Million USD | -653.61% |
| 2001 Q4 | -536.76 Thousand USD | 62.37% |
| 2001 Q3 | -1.42 Million USD | 50.07% |
| 2001 Q1 | -2.59 Million USD | -225.49% |
| 2001 Q2 | -2.85 Million USD | -10.25% |
| 2000 Q4 | 2.06 Million USD | 222.57% |
| 2000 FY | -983.36 Thousand USD | -883.37% |
| 2000 Q3 | -1.68 Million USD | -212.93% |
| 2000 Q2 | -538.28 Thousand USD | 34.78% |
| 2000 Q1 | -825.33 Thousand USD | -725.34% |
| 1999 Q3 | -200 Thousand USD | -200.0% |
| 1999 Q2 | 200 Thousand USD | -33.33% |
| 1999 FY | -100 Thousand USD | -103.13% |
| 1999 Q1 | 300 Thousand USD | -40.0% |
| 1999 Q4 | -100 Thousand USD | 50.0% |
| 1998 Q2 | 1.9 Million USD | 375.0% |
| 1998 Q3 | 400 Thousand USD | -78.95% |
| 1998 Q4 | 500 Thousand USD | 25.0% |
| 1998 Q1 | 400 Thousand USD | -86.67% |
| 1998 FY | 3.2 Million USD | 0.0% |
| 1997 Q1 | 200 Thousand USD | 120.0% |
| 1997 Q3 | -200 Thousand USD | -150.0% |
| 1997 FY | 3.2 Million USD | 218.52% |
| 1997 Q2 | 400 Thousand USD | 100.0% |
| 1997 Q4 | 3 Million USD | 1600.0% |
| 1996 Q4 | -1 Million USD | -11.11% |
| 1996 Q3 | -900 Thousand USD | -28.57% |
| 1996 Q2 | -700 Thousand USD | 22.22% |
| 1996 Q1 | -900 Thousand USD | -80.0% |
| 1996 FY | -2.7 Million USD | -42.11% |
| 1995 FY | -1.9 Million USD | -35.71% |
| 1995 Q2 | -500 Thousand USD | -150.0% |
| 1995 Q4 | -500 Thousand USD | 37.5% |
| 1995 Q3 | -800 Thousand USD | -60.0% |
| 1995 Q1 | -200 Thousand USD | 60.0% |
| 1994 Q2 | -600 Thousand USD | -200.0% |
| 1994 Q4 | -500 Thousand USD | -25.0% |
| 1994 Q3 | -400 Thousand USD | 33.33% |
| 1994 FY | -1.4 Million USD | 26.32% |
| 1994 Q1 | -200 Thousand USD | 0.0% |
| 1993 FY | -1.9 Million USD | 0.0% |
| 1993 Q3 | -700 Thousand USD | -75.0% |
| 1993 Q2 | -400 Thousand USD | 0.0% |
| 1993 Q4 | -200 Thousand USD | 71.43% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -510.257% |
| Cerus Corporation | -30.05 Million USD | -191.615% |
| OrthoPediatrics Corp. | -25.76 Million USD | -240.134% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -725.122% |
| Talis Biomedical Corporation | -66.81 Million USD | -31.167% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -406.701% |
| Inogen, Inc. | -109.38 Million USD | 19.881% |
| Spectral AI, Inc. | -12.98 Million USD | -574.977% |
| Nano-X Imaging Ltd. | -62.58 Million USD | -40.023% |
| CVRx, Inc. | -43.1 Million USD | -103.325% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -2384.099% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -605.174% |
| Orthofix Medical Inc. | -139.11 Million USD | 37.0% |
| Venus Concept Inc. | -28.3 Million USD | -209.58% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | -62.21% |
| Bioventus Inc. | -81.72 Million USD | -7.236% |
| BrainsWay Ltd. | -4.92 Million USD | -1678.75% |
| Envoy Medical, Inc. | -18.37 Million USD | -377.051% |
| electroCore, Inc. | -18.8 Million USD | -366.041% |
| IceCure Medical Ltd | -15.57 Million USD | -462.654% |
| Lucid Diagnostics Inc. | -48.48 Million USD | -80.766% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -407.522% |
| MaxCyte, Inc. | -48.29 Million USD | -81.451% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -633.059% |
| Nexalin Technology, Inc. | -5.69 Million USD | -1438.526% |
| PAVmed Inc | -68.79 Million USD | -27.392% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | -54.941% |
| RxSight, Inc. | -50.08 Million USD | -74.981% |
| Sight Sciences, Inc. | -57.27 Million USD | -53.017% |
| SI-BONE, Inc. | -46.93 Million USD | -86.74% |
| TELA Bio, Inc. | -44.07 Million USD | -98.841% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | -61.845% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | -70.411% |
| LivaNova PLC | -68.49 Million USD | -27.944% |
| 908 Devices Inc. | -42.75 Million USD | -104.965% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 49.457% |
| Nemaura Medical Inc. | -9.59 Million USD | -813.36% |
| NeuroPace, Inc. | -27.17 Million USD | -222.51% |
| LENSAR, Inc. | -12.22 Million USD | -616.649% |
| Apyx Medical Corporation | -17.25 Million USD | -407.787% |
| Cutera, Inc. | -156.23 Million USD | 43.904% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -918.584% |
| BioSig Technologies, Inc. | -28.51 Million USD | -207.376% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | -290.444% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 178.582% |
| Axonics, Inc. | -26.05 Million USD | -236.336% |
| Outset Medical, Inc. | -169.77 Million USD | 48.378% |
| IRIDEX Corporation | -10 Million USD | -775.777% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 19.722% |
| IRadimed Corporation | 20.03 Million USD | 537.419% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -962.935% |
| INVO Bioscience, Inc. | -6.76 Million USD | -1195.064% |
| Telesis Bio, Inc. | -35.15 Million USD | -149.329% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 711.577% |
| Varex Imaging Corporation | 32.1 Million USD | 373.019% |
| Quipt Home Medical Corp. | 3.91 Million USD | 2336.259% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -622.319% |
| Pulmonx Corporation | -61.93 Million USD | -41.502% |
| Dynatronics Corporation | -2.27 Million USD | -3755.572% |
| Modular Medical, Inc. | -17.52 Million USD | -399.966% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -498.668% |
| Semler Scientific, Inc. | 22.25 Million USD | 493.777% |
| InMode Ltd. | 195.66 Million USD | 144.791% |
| Bruker Corporation | 436.9 Million USD | 120.059% |
| Cytosorbents Corporation | -31.2 Million USD | -180.811% |
| DexCom, Inc. | 597.7 Million USD | 114.663% |
| Align Technology, Inc. | 643.33 Million USD | 113.623% |
| Viveve Medical, Inc. | -21.55 Million USD | -306.621% |
| ZimVie Inc. | -30.93 Million USD | -183.264% |
| Movano Inc. | -29.69 Million USD | -195.18% |
| Cytek Biosciences, Inc. | -27.84 Million USD | -214.739% |
| Nexalin Technology, Inc. | -5.69 Million USD | -1438.526% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -2384.099% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 62.424% |
| Profound Medical Corp. | -28.61 Million USD | -206.259% |
| Insulet Corporation | 220 Million USD | 139.836% |
| enVVeno Medical Corporation | -25.23 Million USD | -247.25% |
| Surmodics, Inc. | -5.64 Million USD | -1452.507% |
| iCAD, Inc. | -7.68 Million USD | -1039.797% |
| Nuwellis, Inc. | -17.63 Million USD | -397.102% |
| Biotricity, Inc. | -8.82 Million USD | -892.709% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 29.979% |
| Aethlon Medical, Inc. | -12.63 Million USD | -593.535% |
| InspireMD, Inc. | -21.14 Million USD | -314.506% |
| PAVmed Inc. | -68.79 Million USD | -27.392% |
| BIOLASE, Inc. | -17.93 Million USD | -388.593% |
| Beyond Air, Inc. | -63 Million USD | -39.096% |
| FONAR Corporation | 16.53 Million USD | 630.009% |
| AxoGen, Inc. | -21.46 Million USD | -308.345% |
| Vivani Medical, Inc. | -26.96 Million USD | -225.01% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 585.777% |
| Inari Medical, Inc. | -14.03 Million USD | -524.565% |
| UFP Technologies, Inc. | 57.66 Million USD | 251.982% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -1678.533% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -1289.822% |
| Tenon Medical, Inc. | -15.72 Million USD | -457.252% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -1072.585% |
| Co-Diagnostics, Inc. | -42.7 Million USD | -105.214% |
| AdaptHealth Corp. | -598.4 Million USD | 85.354% |
| Sintx Technologies, Inc. | -13.35 Million USD | -556.079% |
| NanoVibronix, Inc. | -3.43 Million USD | -2450.611% |
| Quanterix Corporation | -49.7 Million USD | -76.332% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -622.319% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -22842.147% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 73.797% |
| TransMedics Group, Inc. | -28.72 Million USD | -205.075% |
| ReWalk Robotics Ltd. | -23.61 Million USD | -271.163% |
| NeuroMetrix, Inc. | -7.15 Million USD | -1125.46% |
| Hyperfine, Inc. | -48.11 Million USD | -82.145% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | -34.775% |
| Biomerica, Inc. | -6.36 Million USD | -1276.457% |
| Bone Biologics Corporation | -9.42 Million USD | -829.531% |
| AVITA Medical, Inc. | -40.4 Million USD | -116.917% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -749.939% |
| Silk Road Medical, Inc | -59.27 Million USD | -47.862% |